enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Ethyl eicosapentaenoic acid - Wikipedia

   en.wikipedia.org/wiki/Ethyl_eicosapentaenoic_acid

   Ethyl eicosapentaenoic acid (E-EPA, icosapent ethyl), sold under the brand name Vascepa among others, is a medication used to treat dyslipidemia [4] and hypertriglyceridemia. [3] It is used in combination with changes in diet in adults with hypertriglyceridemia ≥ 150 mg/dL. Further, it is often required to be used with a statin (maximally ...

3. Omega-3 acid ethyl esters - Wikipedia

   en.wikipedia.org/wiki/Omega-3_acid_ethyl_esters

   D05255. Omega-3-acid ethyl esters are a mixture of ethyl eicosapentaenoic acid and ethyl docosahexaenoic acid, which are ethyl esters of the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) found in fish oil. [3] Together with dietary changes, they are used to treat high blood triglycerides which may reduce the ...

4. Fish oil - Wikipedia

   en.wikipedia.org/wiki/Fish_oil

   Fish oil. Fish oil is oil derived from the tissues of oily fish. Fish oils contain the omega-3 fatty acids eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), precursors of certain eicosanoids that are known to reduce inflammation in the body and improve hypertriglyceridemia. [1][2] There has been a great deal of controversy in the 21st ...

5. Some Fish Oil Doesn't Help Some Patients in Some Countries - AOL

   www.aol.com/news/2013-05-22-some-fish-oil-doesnt...

   Vascepa is highly purified EPA, which decreased LDL cholesterol levels by a statistically significant 6.2% from baseline versus placebo in the aforementioned trial testing patients with moderately ...

6. Latest Research Highlighting VASCEPA®/VAZKEPA® (icosapent ...

   lite.aol.com/tech/story/0022/20240822/9218601.htm

   DUBLIN, Ireland and BRIDGEWATER, N.J., Aug. 22, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced new supported and/or funded subgroup data from the landmark REDUCE-IT ® cardiovascular outcomes trial with VASCEPA ® /VAZKEPA ® (icosapent ethyl), as well as abstracts showcasing the mechanistic activity of eicosapentaenoic acid (EPA) that will be presented at the ...

7. Research Highlighting the Clinical Impact of VASCEPA®/VAZKEPA ...

   lite.aol.com/tech/story/0022/20240909/9227242.htm

   DUBLIN, Ireland and BRIDGEWATER, N.J., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ:AMRN) today announced that new supported and/or funded research on the clinical impact of VASCEPA ® /VAZKEPA (icosapent ethyl) in patients with diabetes and high cardiovascular risk and the anti-Lp(a) oxidation mechanistic effects of eicosapentaenoic acid (EPA) will be presented at the 60 ...

8. Fish oil supplements may raise risk of stroke, heart issues ...

   www.aol.com/news/fish-oil-supplements-may-cause...

   Instead, prescription versions of fish oil, such as Vascepa and Lovaza, are used to counter such risk factors such as high triglycerides, a type of blood fat, in people with cardiovascular disease ...

9. How Do You Solve a Problem Like Vascepa?

   www.aol.com/2012/11/03/how-do-you-solve-a...

   For premium support please call: 800-290-4726 more ways to reach us